Kinase inhibitors possess limited achievement in tumor treatment because tumors circumvent their actions. routes of kinase pathway activation. For instance, RTK upregulation continues to be observed pursuing targeted inhibition of selective kinases (Chandarlapaty et al., 2011; Johannessen et al., 2010; Nazarian et al., 2010; Villanueva et al., 2010); this kinome reprogramming circumvents inhibition of proto-oncogenic… Continue reading Kinase inhibitors possess limited achievement in tumor treatment because tumors circumvent